View source for 18689716. METHODS OF TREATING CANCER (AMGEN INC.)

<!-- JSON-LD markup for search engines:
{"@context":"https://schema.org","@type":"TechArticle","headline":"METHODS OF TREATING CANCER","name":"METHODS OF TREATING CANCER","description":"Provided herein are methods of treating cancer comprising a KRAS G12C mutation in a patient comprising administering to the patient sotorasib and an anti-epidermal growth factor receptor (EGFR) antibo...","datePublished":"2022-09-07","mainEntity":{"@type":"Patent","identifier":"18689716","name":"METHODS OF TREATING CANCER","abstract":"Provided herein are methods of treating cancer comprising a KRAS G12C mutation in a patient comprising administering to the patient sotorasib and an anti-epidermal growth factor receptor (EGFR) antibody in amounts effective to treat the cancer. Further provided herein are methods further comprising administering FOLFIRI (irinotecan, 5-FU and leucovorin) to the patient.","applicationNumber":"18689716","datePublished":"2022-09-07","inventor":[{"@type":"Person","name":"Emily CHAN"},{"@type":"Person","name":"Gregory FRIBERG"},{"@type":"Person","name":"Omar Ali MATHER"},{"@type":"Person","name":"Brett E. HOUK"},{"@type":"Person","name":"Gataree NGARMCHAMNANRITH"},{"@type":"Person","name":"Haby HENARY"},{"@type":"Person","name":"Sandeep DUTTA"}],"applicant":{"@type":"Organization","name":"AMGEN INC."},"additionalProperty":[{"@type":"PropertyValue","name":"IPC Classification","value":"A61K31/519"},{"@type":"PropertyValue","name":"IPC Classification","value":"A61K31/4745"},{"@type":"PropertyValue","name":"IPC Classification","value":"A61K39/395"},{"@type":"PropertyValue","name":"IPC Classification","value":"A61K45/06"},{"@type":"PropertyValue","name":"IPC Classification","value":"A61P35/00"},{"@type":"PropertyValue","name":"CPC Classification","value":"A61K31/519"}]}}
-->

=METHODS OF TREATING CANCER=


==Organization Name==

[[:Category:AMGEN INC.|AMGEN INC.]]


[[Category:AMGEN INC.]]

==Inventor(s)==

[[:Category:Emily Chan of Thousand Oaks CA US|Emily Chan of Thousand Oaks CA US]][[Category:Emily Chan of Thousand Oaks CA US]]

[[:Category:Gregory Friberg of Westlake Village CA US|Gregory Friberg of Westlake Village CA US]][[Category:Gregory Friberg of Westlake Village CA US]]

[[:Category:Omar Ali Mather of Thousand Oaks CA US|Omar Ali Mather of Thousand Oaks CA US]][[Category:Omar Ali Mather of Thousand Oaks CA US]]

[[:Category:Brett E. Houk of Newbury Park CA US|Brett E. Houk of Newbury Park CA US]][[Category:Brett E. Houk of Newbury Park CA US]]

[[:Category:Gataree Ngarmchamnanrith of Los Angeles CA US|Gataree Ngarmchamnanrith of Los Angeles CA US]][[Category:Gataree Ngarmchamnanrith of Los Angeles CA US]]

[[:Category:Haby Henary of Moorpark CA US|Haby Henary of Moorpark CA US]][[Category:Haby Henary of Moorpark CA US]]

[[:Category:Sandeep Dutta of Newbury Park CA US|Sandeep Dutta of Newbury Park CA US]][[Category:Sandeep Dutta of Newbury Park CA US]]

==METHODS OF TREATING CANCER==


This abstract first appeared for US patent application 18689716 titled 'METHODS OF TREATING CANCER

==Original Abstract Submitted==

Provided herein are methods of treating cancer comprising a KRAS G12C mutation in a patient comprising administering to the patient sotorasib and an anti-epidermal growth factor receptor (EGFR) antibody in amounts effective to treat the cancer. Further provided herein are methods further comprising administering FOLFIRI (irinotecan, 5-FU and leucovorin) to the patient.



[[Category:A61K31/519]]
[[Category:A61K31/4745]]
[[Category:A61K39/395]]
[[Category:A61K45/06]]
[[Category:A61P35/00]]
[[Category:CPC_A61K31/519]]